
Moleculin Biotech, Inc.
Moleculin Biotech, Inc. (MBRX)
WebsitePrice
Market cap
Next catalystDec 12-15, 2026Annamycin + cytarabine — MIRACLE (MB-108) · Phase 2/3 dataCompany source ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2FilingApproved
PreINDP1P2FilingApproved
PreINDP1P3FilingApproved